Babusíková O, Zelezníková T, Mlcáková A, Kusenda J, Stevulová L
Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic.
Neoplasma. 2005;52(6):502-9.
Bone marrow hematogones (benign B-lymphocyte precursors) may cause diagnostic problems due to their morphologic and immunophenotypic similarities with neoplastic lymphoblasts. Hematogone populations in presented study containing 358 bone marrow specimens of 251 individuals always exhibited a continuous and complete maturation spectrum of antigen expression typical for normal evolution of B-lineage precursors; lacking aberrant or asynchronous antigen expression. In contrast lymphoblasts of 19 bone marrows of precursors B-ALL patients showed maturation arrest and exhibited several immunophenotypic aberrancies. Hematogones were identified by 4-color flow cytometry using optimal antibody combinations in many bone marrow samples. They were more commonly found in higher numbers in children, and there was found a general decline in hematogones with increasing age. Bone marrow hematogones were separately assessed as hematogones 1 population of early stage and hematogones 2 of mid-stage precursor B-cells, respectively. In some (about 30%) of hematogones a third type hematogones could be assessed in bone marrow samples. This small B-cell subpopulation was defined by CD10-positivity, coexpressing more mature markers CD19,CD20,CD22 and CD45bright. These cells obviously blended with those of mature B-lymphocytes (CD10-negative) on CD45/SSC, and could be better recognized on CD10-gating. Quantitative immunophenotyping of this study completed the percent antigen expression data in two main hematogone subtypes and lymphocytes in 16 bone marrow specimens and precursor B-ALL lymphoblasts in some samples. Increased information on benign B-lymphocyte precursors, especially that of existence of the 3rd type hematogones could provide a basis for better discrimination of B-leukemia cells even in a very small amounts.
骨髓造血细胞(良性B淋巴细胞前体)可能因其与肿瘤性淋巴母细胞在形态学和免疫表型上的相似性而导致诊断问题。在本研究中,对251名个体的358份骨髓标本中的造血细胞群体进行检测,结果显示其始终呈现出B系前体正常发育所特有的连续且完整的抗原表达成熟谱,不存在异常或不同步的抗原表达。相比之下,19例前体B-ALL患者的骨髓中的淋巴母细胞表现出成熟停滞,并呈现出多种免疫表型异常。在许多骨髓样本中,通过使用最佳抗体组合的四色流式细胞术鉴定出了造血细胞。它们在儿童中更常见,数量也更多,并且随着年龄的增长,造血细胞的数量普遍下降。骨髓造血细胞分别被评估为早期的造血细胞1群体和中期前体B细胞的造血细胞2群体。在一些(约30%)骨髓样本中,可以评估出第三种类型的造血细胞。这个小的B细胞亚群由CD10阳性定义,同时共表达更成熟的标志物CD19、CD20、CD22和CD45bright。这些细胞在CD45/SSC上明显与成熟B淋巴细胞(CD10阴性)的细胞混合,并且在CD10门控上能被更好地识别。本研究的定量免疫表型分析完成了16份骨髓标本中两种主要造血细胞亚型和淋巴细胞以及部分样本中前体B-ALL淋巴母细胞的抗原表达百分比数据。关于良性B淋巴细胞前体的更多信息,特别是第三种类型造血细胞的存在,即使对于极少量的B白血病细胞,也能为更好地区分它们提供依据。